- Release Date: 10/03/20 09:50
- Summary: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
- Price Sensitive: Yes
- Download Document 98.41KB
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
- There are more pages in this discussion • 443 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.07 | $6.315M | 5.747M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 28582 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 6293 | 1 |
View Market Depth
| Last trade - 10.20am 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.20 |
Change
0.015 ( 8.36 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.20 | $1.07 | 1073528 | ||
| Last updated 10.41am 02/05/2024 ? | |||||
| MSB (ASX) Chart |